ASXC - Asensus Surgical shares surge on FDA 510K clearance for articulating instruments

Asensus Surgical (ASXC) shares surge more than 25% premarket after the company received FDA 510k clearance for 5 mm diameter articulating instruments, adding to the Senhance Surgical System technology platform.Articulating instruments offer better access to difficult-to-reach areas of the anatomy by providing two additional degrees of freedom.The Senhance Surgical System is a digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning.Articulating instruments are the latest addition to the Senhance Surgical System in the United States, further enhancing surgical performance with robotic precision.

For further details see:

Asensus Surgical shares surge on FDA 510K clearance for articulating instruments